Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges

被引：0
|
作者：
D. H. Solomon
E. Mercer
S. B. Woo
J. Avorn
S. Schneeweiss
N. Treister
机构：
[1] Brigham and Women’s Hospital,Division of Pharmacoepidemiology
[2] Brigham and Women’s Hospital,Division of Rheumatology
[3] Brigham and Women’s Hospital,Department of Medicine
[4] Brigham and Women’s Hospital,Department of Oral Medicine
来源：
Osteoporosis International | 2013年 / 24卷
关键词：
Bisphosphonate; Epidemiology; Osteonecrosis of the jaw; Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：237 / 244
页数：7
相关论文
共 50 条
  • [31] Stress response in periodontal ligament stem cells may contribute to bisphosphonate-associated osteonecrosis of the jaw: A gene expression array analysis
    Shi, Yueqi
    Li, Mengyu
    Yu, Yejia
    Zhou, Yuqiong
    Zhang, Wenjie
    Hua, Hongfei
    Wang, Shaoyi
    MOLECULAR MEDICINE REPORTS, 2020, 22 (03) : 2043 - 2051
  • [32] Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature
    Jan Rustemeyer
    Andreas Bremerich
    Clinical Oral Investigations, 2010, 14 : 59 - 64
  • [33] Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature
    Rustemeyer, Jan
    Bremerich, Andreas
    CLINICAL ORAL INVESTIGATIONS, 2010, 14 (01) : 59 - 64
  • [34] PLATELET-RICH PLASMA IMPROVES WOUND HEALING IN MULTIPLE MYELOMA BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW PATIENTS
    Coviello, V.
    Peluso, F.
    Dehkhargani, S. Z.
    Verdugo, F.
    Raffaelli, L.
    Manicone, P. F.
    D'Addona, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2012, 26 (01) : 151 - 155
  • [35] Incidence of Bisphosphonate-associated Osteonecrosis of the Jaws in Breast Cancer Patients
    Walter, Christian
    Al-Nawas, Bilal
    du Bois, Andreas
    Buch, Laura
    Harter, Philipp
    Groetz, Knut A.
    CANCER, 2009, 115 (08) : 1631 - 1637
  • [36] Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with Zoledronate
    Walter, Christian
    Al-Nawas, Bilal
    Groetz, Knut A.
    Thomas, Christian
    Thueroff, Joachim W.
    Zinser, Viktoria
    Gamm, Heinold
    Beck, Joachim
    Wagner, Wilfried
    EUROPEAN UROLOGY, 2008, 54 (05) : 1066 - 1072
  • [37] Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw A review
    Almazrooa, Soulafa A.
    Woo, Sook-Bin
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2009, 140 (07) : 864 - 875
  • [38] Clinical aspects of bisphosphonate-associated oral osteonecrosis in patients with multiple myeloma
    Gaglioti, Domenico
    Andriani, Alessandro
    Colasanti, Ubalbo
    Papa, Raffaele
    Villiva, Nicoletta
    Riva, Chiara
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2006, 3 (02) : 192 - 197
  • [39] Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
    Kizub, Darya A.
    Miao, Jieling
    Schubert, Mark M.
    Paterson, Alexander H. G.
    Clemons, Mark
    Dees, Elizabeth C.
    Ingle, James N.
    Falkson, Carla I.
    Barlow, William E.
    Hortobagyi, Gabriel N.
    Gralow, Julie R.
    SUPPORTIVE CARE IN CANCER, 2021, 29 (05) : 2509 - 2517
  • [40] Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
    Darya A. Kizub
    Jieling Miao
    Mark M. Schubert
    Alexander H. G. Paterson
    Mark Clemons
    Elizabeth C. Dees
    James N. Ingle
    Carla I. Falkson
    William E. Barlow
    Gabriel N. Hortobagyi
    Julie R. Gralow
    Supportive Care in Cancer, 2021, 29 : 2509 - 2517
12345